38 related articles for article (PubMed ID: 29965874)
1. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
[TBL] [Abstract][Full Text] [Related]
2. Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement.
Šoštarić P; Matić M; Nemanić D; Lučev Vasić Ž; Cifrek M; Pirazzini M; Matak I
Eur J Pharmacol; 2024 Jan; 962():176242. PubMed ID: 38048980
[TBL] [Abstract][Full Text] [Related]
3. Scientific review of the aesthetic uses of botulinum toxin type A.
Park MY; Ahn KY
Arch Craniofac Surg; 2021 Feb; 22(1):1-10. PubMed ID: 33714246
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and central neurobiological effects of botulinum toxin A (BoNT/A) in neuropathic pain: a systematic review.
Moreau N; Korai SA; Sepe G; Panetsos F; Papa M; Cirillo G
Pain; 2024 Mar; ():. PubMed ID: 38452215
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.
Luvisetto S
Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822535
[TBL] [Abstract][Full Text] [Related]
6. Application of botulinum toxin in pregnancy and its impact on female reproductive health.
Li W; Tang M
Expert Opin Drug Saf; 2020 Jan; 19(1):83-91. PubMed ID: 31868020
[No Abstract] [Full Text] [Related]
7. Targets for botulinum toxin in the lower urinary tract.
Cruz F
Neurourol Urodyn; 2014 Jan; 33(1):31-8. PubMed ID: 23775898
[TBL] [Abstract][Full Text] [Related]
8. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
9. Long-distance retrograde effects of botulinum neurotoxin A.
Antonucci F; Rossi C; Gianfranceschi L; Rossetto O; Caleo M
J Neurosci; 2008 Apr; 28(14):3689-96. PubMed ID: 18385327
[TBL] [Abstract][Full Text] [Related]
10. Neurocircuitry underlying the antidepressant effect of retrograde facial botulinum toxin in mice.
Ni L; Chen H; Xu X; Sun D; Cai H; Wang L; Tang Q; Hao Y; Cao S; Hu X
Cell Biosci; 2023 Feb; 13(1):30. PubMed ID: 36782335
[TBL] [Abstract][Full Text] [Related]
11. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
12. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
Rosales RL; Ng AR; Santos MM; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
[TBL] [Abstract][Full Text] [Related]
13. Unilateral whisker pad injection of botulinum toxin type a enhances spatial learning in mice.
Ni LH; Cao SX; Lian H; Hu XY
Neuroreport; 2018 Aug; 29(12):987-992. PubMed ID: 29965874
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
